These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28182994)

  • 1. ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib.
    Wang C; Jette N; Moussienko D; Bebb DG; Lees-Miller SP
    Transl Oncol; 2017 Apr; 10(2):190-196. PubMed ID: 28182994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.
    Kubota E; Williamson CT; Ye R; Elegbede A; Peterson L; Lees-Miller SP; Bebb DG
    Cell Cycle; 2014; 13(13):2129-37. PubMed ID: 24841718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
    Jette NR; Radhamani S; Arthur G; Ye R; Goutam S; Bolyos A; Petersen LF; Bose P; Bebb DG; Lees-Miller SP
    Br J Cancer; 2019 Oct; 121(7):600-610. PubMed ID: 31481733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53.
    Williamson CT; Kubota E; Hamill JD; Klimowicz A; Ye R; Muzik H; Dean M; Tu L; Gilley D; Magliocco AM; McKay BC; Bebb DG; Lees-Miller SP
    EMBO Mol Med; 2012 Jun; 4(6):515-27. PubMed ID: 22416035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition.
    Gilardini Montani MS; Prodosmo A; Stagni V; Merli D; Monteonofrio L; Gatti V; Gentileschi MP; Barilà D; Soddu S
    J Exp Clin Cancer Res; 2013 Nov; 32(1):95. PubMed ID: 24252502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.
    Hong R; Ma F; Zhang W; Yu X; Li Q; Luo Y; Zhu C; Jiang W; Xu B
    BMC Cancer; 2016 Sep; 16(1):725. PubMed ID: 27613518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM-Deficient Cancers Provide New Opportunities for Precision Oncology.
    Jette NR; Kumar M; Radhamani S; Arthur G; Goutam S; Yip S; Kolinsky M; Williams GJ; Bose P; Lees-Miller SP
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.
    Parvin S; Akter J; Takenobu H; Katai Y; Satoh S; Okada R; Haruta M; Mukae K; Wada T; Ohira M; Ando K; Kamijo T
    BMC Cancer; 2023 Apr; 23(1):313. PubMed ID: 37020276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE; Helleday T
    Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
    Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
    Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-small cell lung cancer cells with deficiencies in homologous recombination genes are sensitive to PARP inhibitors.
    Ji W; Weng X; Xu D; Cai S; Lou H; Ding L
    Biochem Biophys Res Commun; 2020 Jan; 522(1):121-126. PubMed ID: 31753490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
    Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
    Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Schmitt A; Knittel G; Welcker D; Yang TP; George J; Nowak M; Leeser U; Büttner R; Perner S; Peifer M; Reinhardt HC
    Cancer Res; 2017 Jun; 77(11):3040-3056. PubMed ID: 28363999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
    Sanmartín E; Muñoz L; Piqueras M; Sirerol JA; Berlanga P; Cañete A; Castel V; Font de Mora J
    Clin Cancer Res; 2017 Nov; 23(22):6875-6887. PubMed ID: 28830922
    [No Abstract]   [Full Text] [Related]  

  • 16. ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms.
    Southgate HED; Chen L; Tweddle DA; Curtin NJ
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32354033
    [No Abstract]   [Full Text] [Related]  

  • 17. Promising Response of Olaparib in Patient With Germline
    Chan KH; Rutazanaa D; Wray C; Thosani N; Yang V; Cen P
    J Investig Med High Impact Case Rep; 2024; 12():23247096241240176. PubMed ID: 38504422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by
    D'Ambrosio C; Erriquez J; Capellero S; Cignetto S; Alvaro M; Ciamporcero E; Di Renzo MF; Perera T; Valabrega G; Olivero M
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
    Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.
    Hou Z; Cui Y; Xing H; Mu X
    Oncol Lett; 2018 Feb; 15(2):1943-1948. PubMed ID: 29434894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.